RIPK1 and glioblastoma: A survey of The Cancer Genome Atlas (TCGA) on expression in GBM tissue of RIPK1, RIPK3, and MLKL revealed overexpression of each protein, as well as a correlation between low expression and longer survival of patients (Supplementary Fig. 6).